Flortran helps founders and businesses build investor-grade valuations and financial models that turn complexity into clarity—and opportunities into outcomes.
| FY24E | FY25E | FY26E | FY27E | |
|---|---|---|---|---|
| Revenue | 78.6 | 95.3 | 116.4 | 142.3 |
| EBITDA | 16.2 | 21.5 | 27.8 | 35.6 |
| Margin | 20.6% | 22.6% | 23.9% | 25.0% |
| Free CF | 10.1 | 14.3 | 18.7 | 24.5 |
Independent valuation using proven methodologies and market insights to determine what your business is worth with confidence.
Learn moreCustom 3-statement models with forecasts, scenarios, and analyses to guide decisions and drive measurable performance outcomes.
Learn moreComprehensive review of your numbers, assumptions, and investor materials to ensure you're ready to raise with full conviction.
Learn moreWe partner with founders and businesses to create clarity, build investor confidence, and transcend limitations—through numbers that tell a compelling story.
Book a Consultation →